BioAge Labs, Inc. (BIOA)
NASDAQ: BIOA · Real-Time Price · USD
23.76
+1.14 (5.04%)
At close: Jun 26, 2026, 4:00 PM EDT
23.55
-0.21 (-0.88%)
After-hours: Jun 26, 2026, 7:20 PM EDT

BioAge Labs Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for BioAge Labs stock have an average target of 49.5, with a low estimate of 23 and a high estimate of 73. The average target predicts an increase of 108.33% from the current stock price of 23.76.

Analyst Consensus: Buy
Target Low Average Median High
Price $23 $49.5 $52 $73
Change -3.20% +108.33% +118.86% +207.24%

Analyst Ratings

The average analyst rating for BioAge Labs stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 133355
Buy 112222
Hold 322222
Sell 000000
Strong Sell 000000
Total 567799

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Roth MKM
Roth MKM
Buy
Reiterates
$36
Buy Reiterates $36 +51.52% Jun 17, 2026
Morgan Stanley
Morgan Stanley
Hold
Maintains
$23
Hold Maintains $23 -3.20% Jun 17, 2026
BTIG
BTIG
Buy
Initiates
$40
Buy Initiates $40 +68.35% May 13, 2026
William Blair
William Blair
Hold
Reiterates
n/a
Hold Reiterates n/a n/a May 11, 2026
Needham
Needham
Buy
Maintains
$50
Buy Maintains $50 +110.44% May 11, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
54.29M
from 9.00M
Increased by 503.61%
Revenue Next Year
35.42M
from 54.29M
Decreased by -34.76%
EPS This Year
-2.49
from -2.24
EPS Next Year
-2.06
from -2.49
Fiscal Year FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028
Period Ending Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028
Revenue
---9.00M54.29M35.42M3.18M
Revenue Growth
----503.61%-34.76%-91.02%
EPS
-23.76-38.17-6.63-2.24-1.39-1.64-2.71
EPS Growth
-------
Forward PE
-------
No. Analysts ----10109
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 483.8M 191.0M
Avg 54.3M 35.4M
Low 2.8M -2.3M

Revenue Growth

Revenue Growth 202620272028
High
5,278.5%
251.8%
Avg
503.6%
-34.8%
Low
-69.2%
-

EPS Forecast

EPS 202620272028
High -2.12 1.15
Avg -2.49 -2.06
Low -3.03 -3.02

EPS Growth

EPS Growth 202620272028
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.